Cannabis Use is Associated with Lower Odds of Prescription Opioid Analgesic Use Among HIV-Infected Individuals with Chronic Pain

We conducted a secondary data analysis of screening interviews conducted as part of a parent randomized trial of financial incentives to improve HIV outcomes among drug users. In a convenience sample of people with HIV and chronic pain, we collected self-report data on demographic characteristics. Our data suggest that new medical cannabis legislation might reduce the need for opioid analgesics for pain management, which could help to address adverse events associated with opioid analgesic use.

Of Ancient Civilizations, Religions & Marijuana.

According to the experts, since the very first time the hallucinatory aspect of this herb entered into human being’s blood stream that led to the sudden out of the blue euphoric and ecstatic feeling, mankind’s been using this plant as a sacred medium for the communion with the spiritual world and to achieve a elated heavenly delight that they thought opened doors to a numinous new realm of higher consciousness

Medical Cannabis, a Beneficial High in Treatment of Blepharospasm? An Early Observation

A retrospective chart review was performed on patients certified for medical cannabis use for blepharospasm from September 2015 to May 2016. Ten patients were certified for medical cannabis use. Five met the inclusion criteria, which was any patient with a diagnosis of BEB receiving standard botulinum toxin treatment who had started medical cannabis treatment by a registered distributor within the state, and was contactable by phone. Four patients discontinued use. Three out of four patients (75%) reported symptomatic improvement. Medical cannabis is an accepted therapy for muscle spastic disorders.

Cannabis research may yield new diet drug, Israeli researcher says

While cannabis science in the U.S. remains heavily politicized and mired in red tape, our international ally, Israel, is racing ahead. On Tuesday, Jan. 16 at 6 p.m., The California Israel Chamber of Commerce, American Friends of Hebrew University, and financial advisors WGD Partners host a V.I.P. cocktail reception and discussion with Dr. Yossi Tam, Director of Cannabinoid Research at…